CAMCEVI is a Subcutaneous Injection, Emulsion in the Human Prescription Drug category. It is labeled and distributed by Accord Biopharma, Inc.. The primary component is Leuprolide Mesylate.
Product ID | 69448-014_d7a8761a-d954-413a-e053-2a95a90a60ee |
NDC | 69448-014 |
Product Type | Human Prescription Drug |
Proprietary Name | CAMCEVI |
Generic Name | Leuprolide |
Dosage Form | Injection, Emulsion |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2022-03-07 |
Marketing Category | NDA / |
Application Number | NDA211488 |
Labeler Name | Accord BioPharma, Inc. |
Substance Name | LEUPROLIDE MESYLATE |
Active Ingredient Strength | 42 mg/.37g |
Pharm Classes | Gonadotropin Releasing Hormone Receptor Agonist [EPC], Gonadotropin Releasing Hormone Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-03-07 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CAMCEVI 90733116 not registered Live/Pending |
Foresee Pharmaceuticals Co., Ltd. 2021-05-25 |
CAMCEVI 87953162 not registered Live/Pending |
FORESEE PHARMACEUTICALS, Co LTD. 2018-06-07 |